ResMed Inventories decreased by 1.1% to $911.88M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.7%, from $862.64M to $911.88M. Over 4 years (FY 2021 to FY 2025), Inventories shows an upward trend with a 19.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Rising inventory relative to sales may indicate slowing demand or overproduction, while declining inventory may signal strong sales or supply constraints.
The aggregate value of all raw materials, work-in-progress, and finished goods held by the company. This metric is a cri...
Benchmark against inventory turnover ratios of peer healthcare and consumer goods companies.
inventories| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $457.03M | $506.64M | $592.15M | $664.94M | $743.91M | $864.85M | $988.96M | $1.01B | $998.01M | $958.23M | $933.21M | $829.46M | $822.25M | $917.98M | $882.10M | $862.64M | $927.71M | $945.81M | $922.05M | $911.88M |
| QoQ Change | — | +10.9% | +16.9% | +12.3% | +11.9% | +16.3% | +14.3% | +2.3% | -1.3% | -4.0% | -2.6% | -11.1% | -0.9% | +11.6% | -3.9% | -2.2% | +7.5% | +2.0% | -2.5% | -1.1% |
| YoY Change | — | — | — | — | +62.8% | +70.7% | +67.0% | +52.1% | +34.2% | +10.8% | -5.6% | -18.0% | -17.6% | -4.2% | -5.5% | +4.0% | +12.8% | +3.0% | +4.5% | +5.7% |